CK Life Sciences International Holdings (HKSE:00775) Long-Term Capital Lease Obligation : HK$436 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Long-Term Capital Lease Obligation?

CK Life Sciences International Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$436 Mil.

CK Life Sciences International Holdings's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (HK$446 Mil) to Jun. 2023 (HK$448 Mil) but then declined from Jun. 2023 (HK$448 Mil) to Dec. 2023 (HK$436 Mil).

CK Life Sciences International Holdings's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (HK$507 Mil) to Dec. 2022 (HK$446 Mil) and declined from Dec. 2022 (HK$446 Mil) to Dec. 2023 (HK$436 Mil).

CK Life Sciences International Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for CK Life Sciences International Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Long-Term Capital Lease Obligation Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

449.48

513.94

507.01

446.25

436.38

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															507.01	476.69	446.25	448.17	436.38

CK Life Sciences International Holdings (HKSE:00775) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

CK Life Sciences International Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

LSI:Germany

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines